If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

Toth C, McDonald D, Oger J, Brownell K. Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease.

Acta Neurol Scand 2006: 114: 124–132. © 2006 The Authors Journal compilation © 2006 Blackwell Munksgaard. Objective – 

Myasthenia gravis (MG) may be associated with the presence of acetylcholine receptor antibodies (AChRAb) [seropositive MG (SPMG)] or their absence [seronegative MG (SNMG)]. Along with features of MG, the presence of the AChRAb may relate to the existence of other immune-mediated diseases. We sought to determine the association of SPMG with other potential autoimmune diseases. Methods – 

A retrospective evaluation of prospectively identified MG patients at a tertiary care center was performed, with patients separated into SPMG and SNMG. Prevalence of other immune-mediated disorders, as well as the epidemiology, sensitivity of diagnostic testing, and thymic pathology, was contrasted between both patient groups. Results – 

Of the 109 MG patients identified, 66% were SPMG. SPMG was associated with a greater likelihood of significant repetitive stimulation decrement, the presence of either thymoma or thymic hyperplasia, and the presence of thyroid disease. In addition, all patients with a diagnosis of diabetes, concurrent with MG, were found to be SPMG. Conclusions – 

AChRAb and SPMG impart not only a distinctive clinical and electrophysiological phenotype of MG, but are also associated with the heightened presence of endocrinological disease.

Keywords: diabetes; myasthenia gravis; thyroid disease

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1600-0404.2006.00649.x

Affiliations: 1: Department of Clinical Neurosciences, University of Calgary and the Calgary Health Region, Calgary, Alberta, Canada 2: College of Medicine, University of Ottawa, Ottawa, Ontario, Canada 3: Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

Publication date: August 1, 2006

Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more